WindRose Health Investors makes private equity investments in businesses that operate within the services sectors of healthcare. We focus on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions.
Windrose Health Investors’ senior investment team has been investing together for over a decade. Collectively we have over 80 years of combined experience working with healthcare companies. Our deep domain knowledge and extensive network of healthcare industry relationships equips us to identify attractive investments and to bring new growth opportunities to each of the companies with which we partner.
Today Windrose Health Investors manages over $700 million of capital and is currently making new investments out of its fourth fund. We always welcome the opportunity to discuss new investment opportunities or to meet talented healthcare executives with whom we may partner. For more information please email us at email@example.com
WindRose Health Investors has developed a disciplined approach to healthcare investing that has consistently delivered successful outcomes for our partners
Serving our Partners
Windrose Health Investors can only achieve its objectives in partnership with others. We strive to be good partners for our management teams by maintaining a culture focused on service. Our primary task is to serve our management teams and provide them with operational resources and growth opportunities that will support them in attaining our shared goals.
Healthcare is an expanding industry; however, not all areas of healthcare are equally positioned for rapid growth. We target sectors that are poised to benefit from industry tailwinds. Within those sectors we target companies that differentiate themselves by delivering innovative and cost-effective solutions.
Creating Growth Opportunities
Windrose Health Investors cultivates relationships with some of the most influential healthcare organizations and leaders, including many of the largest payors and providers of healthcare in the world. We use this network of relationships to provide our portfolio companies with access to growth opportunities in the form of new customers, partnerships and operational resources.
Moving with Urgency
Our portfolio companies compete in a dynamic and rapidly evolving industry. We endeavor to act with a sense of urgency to help our companies rapidly advance new opportunities, maximize operational strength and gain a competitive advantage in the market place. By acting with urgency we aim to accelerate value creation and minimize risk.
Profiting from Growth
Windrose Health Investors targets profitable growth as the primary driver of investment returns rather than financial engineering or market-timing. To that end we take a conservative approach to the use of debt financing in our investments. We believe that this philosophy reduces risk and keeps us appropriately focused on operational excellence in high growth sectors as the key to value creation.
Windrose Health Investors makes investments in healthcare services companies that have a wide array of business models. While we have a consistent focus on cost-effective solutions, that approach has led to investments that span many healthcare sectors including:
- Outsourced payor services
- Revenue cycle management
- Staffing services
- Technology enabled solutions
- Outsources clinical services
- Healthcare providers
- Outsourced pharma services
- Behavioral health
- Managed care
The primary criterion Windrose Health Investors uses to evaluate potential investments is a company’s strategic positioning. As a result, we pursue investments in businesses of various sizes ranging from $25 million to $300 million in enterprise value. Windrose Health Investors will not invest in companies that have venture-stage risks or unprofitable business models.
We target companies headquartered across the United States and selectively overseas.
Windrose Health Investors is comfortable pursuing investments through a range of transaction structures including buyouts, recapitalizations, corporate carve-outs and growth equity investments.
623 Fifth Avenue - 16th floor, New York, NY 10022
p: (212) 887-2105